drugset / Trial / NCT06646354
To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia
RandomizedParallel-groupDouble-blindTreatment
Summary
A Multicenter, Randomized, Double-blind, Active-controlled, Parallel group, Phase 3 trial to Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients with Essential Hypertension and Primary Hypercholesterolemia
Timeline
- Start
- 2025-04-22
- Primary completion
- 2025-05-19
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | — | Oral |
| Subject | Ezetimibe | Unknown | — | Oral |
| Subject | Rosuvastatin | Small molecule | — | Oral |
| Comparator | Candesartan | Unknown | — | Oral |